FI770219A - - Google Patents

Info

Publication number
FI770219A
FI770219A FI770219A FI770219A FI770219A FI 770219 A FI770219 A FI 770219A FI 770219 A FI770219 A FI 770219A FI 770219 A FI770219 A FI 770219A FI 770219 A FI770219 A FI 770219A
Authority
FI
Finland
Application number
FI770219A
Other languages
Finnish (fi)
Inventor
Wilfred Bauer
Francois Gardinaux
Rene Huquenin
Janos Pless
Edmond Sandrin
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH126676A external-priority patent/CH619686A5/de
Priority claimed from CH752476A external-priority patent/CH622773A5/de
Priority claimed from CH752576A external-priority patent/CH621771A5/de
Priority claimed from CH895676A external-priority patent/CH622494A5/de
Priority claimed from CH895576A external-priority patent/CH622493A5/de
Priority claimed from CH920676A external-priority patent/CH622243A5/de
Priority claimed from CH1076376A external-priority patent/CH623027A5/de
Priority claimed from CH1076476A external-priority patent/CH623028A5/de
Priority claimed from CH1206476A external-priority patent/CH623564A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI770219A publication Critical patent/FI770219A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B63—SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
    • B63B—SHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 
    • B63B1/00—Hydrodynamic or hydrostatic features of hulls or of hydrofoils
    • B63B1/02—Hydrodynamic or hydrostatic features of hulls or of hydrofoils deriving lift mainly from water displacement
    • B63B1/10—Hydrodynamic or hydrostatic features of hulls or of hydrofoils deriving lift mainly from water displacement with multiple hulls
    • B63B1/107—Semi-submersibles; Small waterline area multiple hull vessels and the like, e.g. SWATH
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B63—SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
    • B63B—SHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 
    • B63B35/00—Vessels or similar floating structures specially adapted for specific purposes and not otherwise provided for
    • B63B35/44—Floating buildings, stores, drilling platforms, or workshops, e.g. carrying water-oil separating devices
    • B63B35/4413—Floating drilling platforms, e.g. carrying water-oil separating devices
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C07K14/702—Enkephalins with at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ocean & Marine Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Combustion & Propulsion (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Structural Engineering (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Fluid Mechanics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Civil Engineering (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Architecture (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Revetment (AREA)
FI770219A 1976-02-02 1977-01-24 FI770219A (ro)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
CH126676A CH619686A5 (en) 1976-02-02 1976-02-02 Process for the preparation of novel peptides or peptide derivatives
CH752476A CH622773A5 (en) 1976-06-14 1976-06-14 Process for the preparation of novel polypeptides and polypeptide derivatives
CH752576A CH621771A5 (en) 1976-06-14 1976-06-14 Process for the preparation of novel polypeptide derivatives
CH895676A CH622494A5 (en) 1976-07-13 1976-07-13 Process for the preparation of novel polypeptide derivatives
CH895576A CH622493A5 (en) 1976-07-13 1976-07-13 Process for the preparation of novel polypeptide derivatives
CH920876 1976-07-19
CH920676A CH622243A5 (en) 1976-07-19 1976-07-19 Process for the preparation of novel polypeptide derivatives
CH1076376A CH623027A5 (en) 1976-08-25 1976-08-25 Process for the preparation of novel polypeptide derivatives
CH1076476A CH623028A5 (en) 1976-08-25 1976-08-25 Process for the preparation of novel polypeptide derivatives
CH1206476A CH623564A5 (en) 1976-09-23 1976-09-23 Process for the preparation of polypeptide derivatives

Publications (1)

Publication Number Publication Date
FI770219A true FI770219A (ro) 1977-08-03

Family

ID=27579052

Family Applications (1)

Application Number Title Priority Date Filing Date
FI770219A FI770219A (ro) 1976-02-02 1977-01-24

Country Status (14)

Country Link
US (1) US4438103A (ro)
JP (1) JPS5295631A (ro)
AT (1) ATA60577A (ro)
BE (1) BE850941A (ro)
DE (1) DE2702711A1 (ro)
DK (1) DK28377A (ro)
ES (1) ES455495A1 (ro)
FI (1) FI770219A (ro)
FR (1) FR2339590A1 (ro)
GB (1) GB1578873A (ro)
IL (1) IL51360A (ro)
NL (1) NL7700904A (ro)
NZ (1) NZ183212A (ro)
PT (1) PT66137B (ro)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2359817A1 (fr) * 1976-07-27 1978-02-24 Reckitt & Colmann Prod Ltd Nouveaux peptides, leur procede de preparation et composition therapeutique les contenant
DE2735674A1 (de) * 1976-08-09 1978-02-16 Searle & Co 1-substituierte enkephalinderivate
US4259234A (en) * 1976-09-27 1981-03-31 Eli Lilly And Company Analgesic compounds
DE2819277A1 (de) * 1977-05-16 1978-11-23 Sandoz Ag Neue polypeptidderivate, ihre herstellung und verwendung
DE2860579D1 (en) * 1977-09-07 1981-04-23 Sandoz Ag Polypeptides, their preparation and pharmaceutical compositions containing them
NZ188372A (en) * 1977-09-29 1981-05-01 Reckitt & Colmann Prod Ltd Peptide derivatives and pharmaceutical compositions
US4264491A (en) * 1977-10-03 1981-04-28 Eli Lilly And Company Analgesic compounds
US4178371A (en) * 1977-12-15 1979-12-11 Reckitt & Colman Products Limited Tetrapeptide derivatives
US4251439A (en) * 1979-12-17 1981-02-17 Eli Lilly And Company Pharmacologically active peptides
JPS5756447A (en) * 1980-07-17 1982-04-05 Sandoz Ag Novel pentapeptides
US4322340A (en) * 1980-10-20 1982-03-30 Eli Lilly And Company Pharmacologically active peptides
US4322339A (en) * 1980-10-20 1982-03-30 Eli Lilly And Company Pharmacologically active peptides

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371463A (en) 1977-02-17 1983-02-01 The United States Of America As Represented By The Department Of Health And Human Services Enzyme-resistant opiate pentapeptides
US4322342A (en) 1977-06-20 1982-03-30 Eli Lilly And Company Analgesic compounds
GB1604850A (en) 1977-11-24 1981-12-16 Wellcome Found Biologically active peptides
US4264491A (en) 1977-10-03 1981-04-28 Eli Lilly And Company Analgesic compounds
US4278596A (en) 1978-08-08 1981-07-14 American Home Products Corporation Analgesic pentapeptides
US4247543A (en) 1979-04-09 1981-01-27 Sandoz Ltd. Organic compounds
NL8005121A (nl) 1979-09-20 1981-03-24 Erba Farmitalia Biologisch actieve peptiden.
US4283329A (en) 1979-12-17 1981-08-11 Eli Lilly And Company Pharmacologically active peptides
US4265808A (en) 1979-12-17 1981-05-05 Eli Lilly And Company Pharmacologically active peptides
US4351763A (en) 1979-12-17 1982-09-28 Eli Lilly And Company Pharmacologically active peptides
US4322339A (en) 1980-10-20 1982-03-30 Eli Lilly And Company Pharmacologically active peptides

Also Published As

Publication number Publication date
NL7700904A (nl) 1977-08-04
ATA60577A (de) 1984-03-15
BE850941A (fr) 1977-08-01
DE2702711A1 (de) 1977-08-04
GB1578873A (en) 1980-11-12
IL51360A0 (en) 1977-03-31
DK28377A (da) 1977-08-03
PT66137A (fr) 1977-03-01
NZ183212A (en) 1979-12-11
PT66137B (fr) 1978-10-13
ES455495A1 (es) 1984-07-16
FR2339590B1 (ro) 1981-09-04
IL51360A (en) 1981-10-30
JPS5295631A (en) 1977-08-11
US4438103A (en) 1984-03-20
FR2339590A1 (fr) 1977-08-26

Similar Documents

Publication Publication Date Title
JPS52110627U (ro)
JPS51155806U (ro)
CH608466A5 (ro)
BE861183A (ro)
BG23105A1 (ro)
BG23276A1 (ro)
BG23295A1 (ro)
BG23302A1 (ro)
BG23397A1 (ro)
BG23458A1 (ro)
BG23474A2 (ro)
CH592988A5 (ro)
CH593248A5 (ro)
CH593347A5 (ro)
CH594276A5 (ro)
CH596023A5 (ro)
CH597059A5 (ro)
CH597285A5 (ro)
CH597372A5 (ro)
CH597415A5 (ro)
CH597484A5 (ro)
CH598518A5 (ro)
CH599828A5 (ro)
CH600922A5 (ro)
CH601084A5 (ro)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SANDOZ AG